Navigation Links
Nuvelo Announces Phase 2 SONOMA-3 Trial Did Not Meet Target Product Profile and Discontinues Alfimeprase Development
Date:3/17/2008

phoma therapeutic antibodies and Wnt signaling pathway therapeutics to further expand its pipeline and create additional partnering and licensing opportunities.

Information about Nuvelo is available at our website at http://www.nuvelo.com or by phoning 650-517-8000.

This press release contains "forward-looking statements," which include statements regarding the timing, progress and anticipated completion of Nuvelo's clinical stage and research programs, the anticipated availability of top-line data, projected operating expenses and cash usage and the potential benefits that patients may experience from the use of our clinical stage compounds, which statements are hereby identified as "forward-looking statements" for purposes of the safe harbor provided by the Private Securities Litigation Reform Act of 1995. Such statements are based on our management's current expectations and involve risks and uncertainties. Actual results and performance could differ materially from those projected in the forward-looking statements as a result of many factors, including, without limitation, uncertainties relating to drug discovery and the regulatory approval process; clinical development processes; enrollment rates for patients in our clinical trials; changes in relationships with strategic partners and dependence upon strategic partners for the performance of critical activities under collaborative agreements; and the impact of competitive products and technological changes. These and other factors are identified and described in more detail in Nuvelo's filings with the SEC, including without limitation Nuvelo's annual report on Form 10-K for the year ended December 31, 2007 and subsequent filings. We disclaim any intent or obligation to update these forward-looking statements.


'/>"/>
SOURCE Nuvelo, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Nuvelo Initiates Phase 1 Clinical Trial of Thrombin Inhibitor, NU172
2. Nuvelo Begins Phase 2 Trial and Receives Fast Track Status for Alfimeprase in Patients With Acute Ischemic Stroke
3. Nuvelo Announces Alfimeprase SONOMA-2 Catheter Occlusion Data Presentation Webcast and Conference Call
4. Nuvelo Re-Initiates SONOMA-3 Trial of Alfimeprase in Patients With Catheter Occlusion
5. MacroChem Announces Presentation of Pexiganan Phase 3 Study Results for Topical Treatment of Diabetic Foot Infection
6. Synbiotics Corporation Announces Human Submission for FluDetect(R)
7. Raven Announces Initiation of a RAV12 Phase 2 Clinical Trial in Metastatic Pancreatic Cancer
8. Genta Incorporated Announces Fourth Quarter and Year End 2007 Financial Results and Corporate Highlights
9. Progen Announces Commencement of Global Phase 3 Study for PI-88 in Post- Resection Liver Cancer
10. Inclinix Announces New Patent for Expert System Platform
11. Genzyme Announces Presentation of New Positive Data on Carticel(R)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2015)... The International Myeloma Foundation (IMF) – improving ... toward prevention and a cure – today commended Representative ... resolution (H. Res. 174) that supports the designation of ... Awareness Month." Currently there are more than ... 110,000 new cases are diagnosed yearly, according to the ...
(Date:3/27/2015)... 27, 2015 RnRMarketResearch.com adds ... market research report of 52 pages with latest ... intelligence library. The report "Visceral Pain - Pipeline ... therapeutic development for Visceral Pain, complete with comparative ... target, mechanism of action (MoA), route of administration ...
(Date:3/26/2015)... , March 26, 2015  The Burzynski ... a study independently conducted by the Department of ... Japan have been published. The ... 5-fluorouracil hepatic arterial infusion as post-operative adjuvant therapy ... metastasis of the liver. A ...
Breaking Medicine Technology:The International Myeloma Foundation (IMF) Secures the Introduction of a Federal Resolution Recognizing March 2015 as "National Multiple Myeloma Awareness Month" 2Visceral Pain Pipeline Review H1 2015 Market Research Report 2Visceral Pain Pipeline Review H1 2015 Market Research Report 3Visceral Pain Pipeline Review H1 2015 Market Research Report 4
... , , SAN ... ) today reported that a recent medical journal article highlights the ... patients with non-healing wounds. , , (Logo: ... the Journal of the American Academy of Physician Assistants, (JAAPA, August ...
... , SAN DIEGO, Aug. 26 Imagenetix, Inc. ... , , To all shareholders and supporters of Imagenetix, ... at the company. It is my intention to provide periodic communication ... to you on topical issues and to provide a uniform status report ...
Cached Medicine Technology:Cardium Reports Non-Healing Wounds Continue to Challenge Patients and Healthcare Providers 2Cardium Reports Non-Healing Wounds Continue to Challenge Patients and Healthcare Providers 3Cardium Reports Non-Healing Wounds Continue to Challenge Patients and Healthcare Providers 4Cardium Reports Non-Healing Wounds Continue to Challenge Patients and Healthcare Providers 5Cardium Reports Non-Healing Wounds Continue to Challenge Patients and Healthcare Providers 6Cardium Reports Non-Healing Wounds Continue to Challenge Patients and Healthcare Providers 7Cardium Reports Non-Healing Wounds Continue to Challenge Patients and Healthcare Providers 8Cardium Reports Non-Healing Wounds Continue to Challenge Patients and Healthcare Providers 9Cardium Reports Non-Healing Wounds Continue to Challenge Patients and Healthcare Providers 10Cardium Reports Non-Healing Wounds Continue to Challenge Patients and Healthcare Providers 11Letter to Shareholders From Imagenetix, Inc. President/CEO William Spencer 2Letter to Shareholders From Imagenetix, Inc. President/CEO William Spencer 3Letter to Shareholders From Imagenetix, Inc. President/CEO William Spencer 4Letter to Shareholders From Imagenetix, Inc. President/CEO William Spencer 5
(Date:3/27/2015)... The Monogamy Method - a new ... Jason Rogers has just been released to the public ... surrounding the course's launch has caught the attention of ... review of the new program. , "Many women report ... suddenly start pulling away or expressing interest in other ...
(Date:3/27/2015)... March 27, 2015 Wellness for Cancer–the ... business criteria for the spa and wellness industry–has certified ... who have experienced or are living with cancer. ... Wellness 365® Network, will be identified with a special ... a provider of safe, therapeutic services for cancer patients. ...
(Date:3/27/2015)... Deer, Alberta (PRWEB) March 27, 2015 In ... until then, prevented her from working, Monica K. arrived at ... in the mending department quiet, defensive and scared. The owners ... Placement & Support Services (EPSS) to offer jobs to ... does take patience and a willingness to begin with the ...
(Date:3/27/2015)... Tampa, FL (PRWEB) March 27, 2015 Florida ... Bay Storm as the team’s exclusive health care provider for ... care provider, Florida Hospital provides medical care and an athletic ... Bay Storm will kick off its season against the Cleveland ... , “This partnership is extremely important to us as ...
(Date:3/27/2015)... York (PRWEB) March 27, 2015 The ... ) that allege the statin medication increases the risk ... granted Pfizer Inc.’s Motion to Dismiss four individual cases ... a Case Management Order issued in the U.S. District ... Court determined that the dismissals were warranted because the ...
Breaking Medicine News(10 mins):Health News:The Monogamy Method - Review Of Samantha Sanderson & Jason Rogers' Relationship Program Released 2Health News:Hands On HealthCare Massage Therapy & Wellness Day Spa Certified as “Cancer Aware” by Wellness for Cancer and Recognized on Spafinder.com 2Health News:Hands On HealthCare Massage Therapy & Wellness Day Spa Certified as “Cancer Aware” by Wellness for Cancer and Recognized on Spafinder.com 3Health News:Hands On HealthCare Massage Therapy & Wellness Day Spa Certified as “Cancer Aware” by Wellness for Cancer and Recognized on Spafinder.com 4Health News:Red Deer Uniforms Shop Celebrates 3rd Year Sewing Hope for the Challenged 2Health News:Red Deer Uniforms Shop Celebrates 3rd Year Sewing Hope for the Challenged 3Health News:Florida Hospital Is Kicking off the 2015 Season as the Exclusive Health Care Provider for the Tampa Bay Storm 2Health News:Florida Hospital Is Kicking off the 2015 Season as the Exclusive Health Care Provider for the Tampa Bay Storm 3Health News:Lipitor Lawsuits Move Forward in Federal Multidistrict Litigation, as Court Rules on Pfizer’s Motion to Dismiss Certain Cases 2Health News:Lipitor Lawsuits Move Forward in Federal Multidistrict Litigation, as Court Rules on Pfizer’s Motion to Dismiss Certain Cases 3
... that the cutting-edge research study of human stem cells ... fronts particularly how the transplanted cells did ... R. Sanberg, DSc, PhD, Distinguished Professor of Neurosurgery and ... at USF Health, wrote the commentary Neural Stem Cells ...
... in low and middle-income countries can turn out economical if ... was reached by A UCSF-led team of researchers. They ... South Africa, Uganda, Russia and Mexico. They not only saw ... that the efficiency of the program was much enhanced. ...
... herbal remedy since the times of the ancient Greeks and ... with U.S. retail sales of nearly nine million dollars . ... published by SAGE, contains a summary of current research on ... in milk thistle. ,The special issue features new ...
... Actress Lindsay Lohan has revealed that her latest stint in rehab has ... she had too much of pressure on her shoulders, and that she ... my life. I didn't have a good grip on it and I ... and I had too much pressure on my shoulders," the Sun quoted ...
... new study has found that good health habits of a person ... ,The study, published in the journal Health Services Research, has ... spouse take up a healthy lifestyle. ,When one spouse ... a sleeve for a flu shot, the other spouse is more ...
... class of medications known as incretin-based therapy, which act ... modest effectiveness and favorable weight change outcomes for ... an alternative to other hypoglycemic therapies. ,Current ... adverse effects such as weight gain or hypoglycemia (low ...
Cached Medicine News:Health News:Stem Cells Research in Parkinsons Disease 2Health News:HIV Prevention Programs on a Massive Scale Turn Out Economical 2Health News:Milk Thistle Extract Effective in Cancer Treatment 2Health News:A Role Model Spouse can Pass on Good Health Habits 2Health News:Alternative Option for Type2 Diabetes Treatment 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: